Section Arrow
Quote
ADPT.NASDAQ
- Adaptive Biotechnologies Corp
Quotes are at least 15-min delayed:2025/07/20 13:16 EDT
Regular Hours
Last
 10.39
-0.11 (-1.05%)
Day High 
10.77 
Prev. Close
10.5 
1-M High
12.43 
Volume 
1.44M 
Bid
10.25
Ask
10.4
Day Low
10.25 
Open
10.66 
1-M Low
10.12 
Market Cap 
1.60B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 11.51 
20-SMA 11.37 
50-SMA 10.28 
52-W High 12.43 
52-W Low 3.845 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.95/-1.19
Enterprise Value
1.67B
Balance Sheet
Book Value Per Share
1.25
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
178.96M
Operating Revenue Per Share
1.25
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TELOTelomir Pharmaceuticals2.28+1.07+88.43%-- 
SRPTSarepta Therapeutics14.075-7.895-35.94%15.76PE
NCNANuCana plc0.0477+0.0009+1.92%-- 
RXRXRecursion Pharmaceuticals5.84+0.32+5.80%-- 
MEIPMEI Pharma5.92+1.42+31.56%1.09PE
Quotes are at least 15-min delayed：2025/07/20 13:16 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product,clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is alsoavailable as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.